15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Cameco Corp, 7 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $97.00 to $175.00, a moderate spread. The average target of $133.03 sits 30% above the current $102.00. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.51 next quarter toward $2.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy778%
Hold222%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Cameco Corp.
As of Sep, 6 of 8 firms rate CCJ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CCJ EPS & revenue forecast
EPS · NEXT QUARTER
$0.51
Range $0.28 – $0.75 · 8 analysts · +2% YoY
Next period, 8 analysts expect Cameco Corp to earn $0.51 a share (range $0.28 – $0.75), versus $0.50 a year earlier. Full-year consensus is $1.49, growing to $2.62 the year after.
REVENUE · NEXT QUARTER
$1.1B
Range $918.2M – $1.3B · 8 analysts · -10% YoY
Revenue is expected to reach $1.1B (range $918.2M – $1.3B), -9.8% year-over-year. Full-year consensus is $3.5B, rising to $4.0B next year.
Top analysts covering Cameco Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CCJ.
#1
AW
Andrew Wong
RBC Capital
Buy
$175.00+71.6% to target
Coverage
—
+ Follow
#2
RG
Richard Garchitorena
Barclays
Hold
$97.00-4.9% to target
Coverage
—
+ Follow
#3
BL
Brian Lee
Goldman Sachs
Buy
$133.00+30.4% to target
Coverage
—
+ Follow
#4
GE
George Eadie
UBS
Buy
$166.00+62.8% to target
Coverage
—
+ Follow
#5
GL
Gordon L. Johnson
GLJ Research
Buy
$152.60+49.6% to target
Coverage
—
+ Follow
CCJ stock forecast FAQ
What is CCJ's average 12-month price target?+
The 8 analysts with a live target average $133.03 for Cameco Corp over the next 12 months, ranging from a $175.00 high to a $97.00 low.
Is CCJ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 7 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CCJ?+
The Street-high target is $175.00 (RBC Capital), and the Street-low is $97.00 (Barclays). The average of all 8 active targets is $133.03.
How many Wall Street analysts cover CCJ?+
9 analysts have an active rating on Cameco Corp, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering CCJ?+
Among analysts who currently cover CCJ, Andrew Wong of RBC Capital has the strongest overall Quantellect track record. Their current call is Buy with a $175.00 target.
What is Cameco Corp's projected EPS for next quarter?+
The consensus estimate is $0.51 per share (range $0.28 – $0.75) across 8 analysts. Full-year EPS is projected at $1.49, rising to $2.62 the following year.
How much revenue is Cameco Corp expected to report next quarter?+
Consensus revenue is $1.1B (range $918.2M – $1.3B). Full-year revenue is projected at $3.5B, growing to $4.0B next year.
Have analysts been upgrading or downgrading CCJ lately?+
As of Sep, 6 of 8 firms rate CCJ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CCJ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Truist Securities
